Skip To Content
 

Search:

  

Diagnostic Imaging Pathways - Solitary Pulmonary Nodule
PathwaysHome
Flow Chart
Image gallery
Teaching Points
References
PDF Version

References

  1. Tuddenham WI. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. Am J Roentgenol 1984;43:509-17. (Glossary)
  2. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003;123:89S-96S. (Review article)
  3. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-42. (Review article)
  4. Mahoney MC, Shipley RI, Cocaran HL, et al. CT demonstration of calcification in carcinoma of the lung. Am J Roentgenol 1990;154:255-8. (Level III evidence)
  5. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73-80. (Level II evidence). Click here to view reference
  6. Shaham D, Guralnik. The solitary pulmonary nodule: radiologic considerations. Semin Ultrasound CT MRI 2000;21:97-115. (Review article)
  7. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914-24. (Level II evidence). Click here to view reference
  8. Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioalveolar lung carcinoma. J Nucl Med 1998;39:1016-20. (Level III evidence)
  9. Erasmus JJ, McAdams HP, Patz EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG-PET. AJR Am J Roentgenol 1998;170:1369-73. (Level III evidence)
  10. Coleman RE. PET in lung cancer. J Nucl Med 1999;40:814-20. (Review article)
  11. Valk PE, Pounds TR, Hopkins DM, et al. Staging lung cancer by PET imaging. Ann Thorac Surg 1995;60:1573-82. (Level III evidence)
  12. Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med 2003;138:724-35. (Level II evidence). Click here to view reference
  13. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647-9. (Level IV evidence)
  14. Higashi K, Ueda Y, Sakuma T, et al. Comparison of (18F)FDG PET and 201T1 SPECT in evaluation of pulmonary nodules. J Nucl Med 2001;42:1489-96. (Level III evidence)
  15. Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18- fluorodeoxyglucose uptake in pneumonia. J Nucl Med 1998;39:1267-9. (Level IV evidence)
  16. Goo JM, Im JG, Do KH, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000;216:117-21. (Level III evidence)
  17. Gaetre SC, Meyer CA, et al. Fat containing lesions of the chest. Radiographics 2002;22:561-78. (Review article)
  18. Erasmus JJ, Connolly JE, et al. Solitary Pulmonary Nodules I. Morphologic evaluation and differentiation of benign and malignant lesions. Radiographics 2000;20:43-58. (Review article)
  19. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Radiology 1993;186:405-13. (Level III evidence)
  20. MacMahon H, Austin JH, Gamsu G et al. Guidelines for management of small pulmonary nodules dectected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400. (Review article) Click here to view reference
  21. Swensen SJ, Jett JR, Hartman TE et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003; 226:756-761. (Level II evidence) Click here to view reference
  22. Jeong YJ, Lee KS, Jeong SY et al. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 2005; 237:675-683. (Level III evidence)
  23. Herder GJ, van Tinteren H, Golding RP et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005; 128:2490-2496. (Level III evidence)
  24. Ost D, Fein A. Management strategies for the solitary pulmonary nodule. Curr Opin Pulm Med 2004; 14:272-278. (Review article)
  25. Pepe G, Rossetti C, Sironi S et al. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study. Nucl Med Commun 2005; 26:831-837.(Level II evidence)
  26. Herder GJ, Golding RP, Hoekstra OS et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004; 31:1231-1236. (Level II evidence)
  27. Lowe VJ, Fletcher JW, Gobar L et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075-1084. (Level III evidence)
  28. Nomori H, Watanabe K, Ohtsuka M, Naruke T et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3cm in diameter, with special reference to the CT images. Lung Cancer 2004; 45:29-30. (Level III evidence)

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.

Get Adobe Reader

Legal Matters